AMGN Jun 2023 140.000 put

OPR - OPR Prezzo differito. Valuta in USD.
0,0100
0,0000 (0,00%)
Alla chiusura: 10:02AM EDT
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente0,0100
Aperto0,0100
Denaro0,0000
Lettera0,1500
Prezzo d'esercizio140,00
Scadenza2023-06-16
Min-Max giorno0,0100 - 0,0100
Contratto - Min-MaxN/D
Volume3
Open Interest6
  • GlobeNewswire

    Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease

    Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery